Your browser doesn't support javascript.
loading
Exploring the epidemiology of carbapenem-resistant Gram-negative bacteria in west London and the utility of routinely collected hospital microbiology data.
Freeman, R; Moore, L S P; Charlett, A; Donaldson, H; Holmes, A H.
Afiliación
  • Freeman R; The National Centre for Infection Prevention and Management, Imperial College London, Du Cane Road, London W12 0NN, UK rachel.freeman@phe.gov.uk.
  • Moore LS; The National Centre for Infection Prevention and Management, Imperial College London, Du Cane Road, London W12 0NN, UK Imperial College Healthcare NHS Trust, Du Cane Road, London W12 0HS, UK.
  • Charlett A; Public Health England, 61 Colindale Avenue, London NW9 5EQ, UK.
  • Donaldson H; Imperial College Healthcare NHS Trust, Du Cane Road, London W12 0HS, UK.
  • Holmes AH; The National Centre for Infection Prevention and Management, Imperial College London, Du Cane Road, London W12 0NN, UK Imperial College Healthcare NHS Trust, Du Cane Road, London W12 0HS, UK.
J Antimicrob Chemother ; 70(4): 1212-8, 2015 Apr.
Article en En | MEDLINE | ID: mdl-25525198
ABSTRACT

OBJECTIVES:

The objective of this study was to identify carbapenem-resistant organisms using routinely collected local microbiology data and describe the epidemiology of carbapenem resistance in two London teaching hospitals.

METHODS:

Data on inpatients infected or colonized with Gram-negative organisms between March 2009 and February 2012 were extracted. A computer algorithm was developed incorporating internationally recognized criteria to distinguish carbapenem-resistant organisms. Multivariable analysis was conducted to identify factors associated with infection or colonization with carbapenem-resistant organisms. Binomial regression was performed to detect changes in resistance trends over time.

RESULTS:

Yearly incidence of carbapenem resistance was observed to be increasing, with significant increasing trends in Acinetobacter baumannii (47.1% in 2009-10 to 77.2% in 2011-12; P<0.001) and Enterobacter spp. (2.2% in 2009-10 to 11.5% in 2011-12; P<0.001). Single-variable and multivariable analysis demonstrated differences in the proportion of carbapenem-resistant isolates across all variables investigated, including age, sex and clinical specialty; in the latter organism-specific niches were identified. Patients in the youngest age group (16-24 years old) had the highest odds of being infected or colonized with carbapenem-resistant isolates of Escherichia coli, Klebsiella spp. or Pseudomonas aeruginosa. Furthermore, proportions of carbapenem-resistant organisms differed between the hospitals.

CONCLUSIONS:

Carbapenem resistance is an emerging problem within the UK inpatient healthcare setting. This is not an issue confined to the Enterobacteriaceae and fine-resolution surveillance is needed to identify at-risk groups. Regular analysis of routinely collected data can provide insight into the evolving carbapenem-resistance threat, with the ability to inform efforts to prevent the spread of resistance.
Asunto(s)
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Carbapenémicos / Infecciones por Bacterias Gramnegativas / Resistencia betalactámica / Bacterias Gramnegativas / Antibacterianos Tipo de estudio: Prognostic_studies / Screening_studies Límite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged País/Región como asunto: Europa Idioma: En Revista: J Antimicrob Chemother Año: 2015 Tipo del documento: Article País de afiliación: Reino Unido

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Carbapenémicos / Infecciones por Bacterias Gramnegativas / Resistencia betalactámica / Bacterias Gramnegativas / Antibacterianos Tipo de estudio: Prognostic_studies / Screening_studies Límite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged País/Región como asunto: Europa Idioma: En Revista: J Antimicrob Chemother Año: 2015 Tipo del documento: Article País de afiliación: Reino Unido